EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Genotype–Phenotype Correlations of Monoallelic PFIC Variants in Pediatric Liver Disease: A Multicenter Retrospective Cohort Study

Brett J Hoskins iD, Tiziano Pramparo, Chaowapong Jarasvaraparn iD, Michael J Wilsey iD, Voytek Slowik iD, Lakshmi Kunam, Janis M Stoll iD, Ruben E Quiros-Tejeira iD, Simon Lam, Wikrom Karnsakul iD

American Journal of Medical Genetics Part A · 2026-12 · 200 (12) · 2692-2707

DOI: 10.1002/ajmg.a.70250 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 20.07.2026. Verfasst von Brett J Hoskins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Riley Hospital for Children, Indiana University School of…. Hauptthemen laut MEDLINE: Cholestasis, Intrahepatic, Genetic Association Studies, Liver Diseases, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mirum Pharmaceuticals, Inc., Travere Therapeutics, Inc., Albireo Pharma, Inc., an Ipsen Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive familial intrahepatic cholestasis (PFIC) is classically caused by biallelic pathogenic variants, yet monoallelic variants of uncertain significance (VUS) in PFIC‐associated genes are increasingly identified in children with cholestasis, creating diagnostic uncertainty. We conducted a multicenter cohort study of children with liver disease and/or cholestasis harboring monoallelic VUS in ATP8B1 , ABCB11 , ABCB4 , TJP2 , or NR1H4 . Clinical and longitudinal data were analyzed, and variant frequencies were compared with population data from gnomAD. Twenty‐six children with 37 monoallelic PFIC‐gene VUS met inclusion criteria, and multigenic variant burden was common (73.1%). PFIC‐like biochemical patterns were observed in 42.3% but were frequently transient, and no patient met criteria for monogenic PFIC on longitudinal follow‐up. Severe liver outcomes, including transplantation in two patients, occurred in a subset of patients with ABCB4 and/or ATP8B1 VUS and multigenic burden, along with competing clinical factors. Among 22 variants with population data, 11 (50%) demonstrated significant enrichment after multiple‐testing correction, most commonly involving ABCB4 . These findings suggest that monoallelic PFIC‐associated variants currently classified as VUS are unlikely to represent monogenic disease drivers in isolation and may instead contribute within multigenic or susceptibility‐based contexts. Population‐level enrichment, particularly involving ABCB4 , further supports careful phenotype‐anchored, longitudinal interpretation in pediatric liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholestasis, IntrahepaticGenetic Association StudiesLiver DiseasesGenetic Predisposition to DiseaseHumansFemaleMaleChild, PreschoolInfantChildATP Binding Cassette Transporter, Subfamily B, Member 11Retrospective StudiesATP Binding Cassette Transporter, Subfamily BAllelesMutationAdenosine TriphosphatasesAdolescentPhenotype

Stichwörter der Autor:innen

ABCB4VUScholestasisgenetic susceptibilitymultigenic inheritanceprogressive familial intrahepatic cholestasisvariant of uncertain significance

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 11ATP Binding Cassette Transporter, Subfamily BABCB11 protein, humanATP8B1 protein, humanmultidrug resistance protein 3Adenosine Triphosphatases

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Mirum Pharmaceuticals, Inc., Foster City, California, USA.
  • Department of Gastroenterology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of Nebraska Medical Center, Omaha, Nebraska, USA.

ORCID-Profile: Brett J Hoskins, Chaowapong Jarasvaraparn, Michael J Wilsey, Voytek Slowik, Janis M Stoll, Ruben E Quiros-Tejeira, Wikrom Karnsakul

Förderung

  • Mirum Pharmaceuticals, Inc.
  • Travere Therapeutics, Inc.
  • Albireo Pharma, Inc., an Ipsen Company
  • Travere Therapeutics

Zitieren

APA

Hoskins, B. J., Pramparo, T., Jarasvaraparn, C., Wilsey, M. J., Slowik, V., Kunam, L., Stoll, J. M., Quiros-Tejeira, R. E., Lam, S., & Karnsakul, W. (2026). Genotype–Phenotype Correlations of Monoallelic PFIC Variants in Pediatric Liver Disease: A Multicenter Retrospective Cohort Study. American Journal of Medical Genetics Part A, 200(12), 2692-2707. https://doi.org/10.1002/ajmg.a.70250

Vancouver

Hoskins BJ, Pramparo T, Jarasvaraparn C, Wilsey MJ, Slowik V, Kunam L, et al. Genotype–Phenotype Correlations of Monoallelic PFIC Variants in Pediatric Liver Disease: A Multicenter Retrospective Cohort Study. American Journal of Medical Genetics Part A. 2026;200(12):2692-2707. doi:10.1002/ajmg.a.70250

BibTeX
@article{Hoskins2026,
  author = {Hoskins, Brett J and Pramparo, Tiziano and Jarasvaraparn, Chaowapong and Wilsey, Michael J and Slowik, Voytek and Kunam, Lakshmi and Stoll, Janis M and Quiros-Tejeira, Ruben E and Lam, Simon and Karnsakul, Wikrom},
  title = {Genotype–Phenotype Correlations of Monoallelic PFIC Variants in Pediatric Liver Disease: A Multicenter Retrospective Cohort Study},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  volume = {200},
  number = {12},
  pages = {2692--2707},
  doi = {10.1002/ajmg.a.70250}
}
Kostenlos starten →